Multidrug-resistant (MDR) Acinetobacter baumanii (A. baumanii) caused hospital acquired infection, typically in critical-ill patients with medical devices. This is a retrospective descriptive study on epidemiology and microbiology data to determine the antimicrobial susceptibility pattern of MDR-Acinetobacter baumanii isolates from a teaching hospital in Tangerang 
Materials and Methods
This study was conducted in Siloam General Hospital, a new teaching hospital with 200 beds located in Tangerang, Indonesia. This was a retrospective descriptive study on epidemiology and microbiology data. The epidemiology data were collected from medical records of admitted patients with A. baumanii infection/colonization from January 2013 to December 2014. Microbiology and antimicrobial susceptibility results were extracted from laboratory data system and converted into a format which used for data analysis. The categorical data and antimicrobial susceptibility were presented as number and percentage. Identification and antibiotic susceptibility testing of all isolates was performed by an automated method from VITEX-2 Compact  (Biomérieux, France). The Interpretation of breakpoints was defined by guideline from Clinical and Laboratory Standard Institute (CLSI) [9] . Escherichia coli ATCC  25922 and Pseudomonas aeruginosa ATCC 27853  were used as control isolate for susceptibility testing.
Results
The total number of isolates was 84, consisted of 45 and 39 in 2013 and 2014 consecutively. The highest number isolate of MDR-A. baumanii infection was observed in patients suffering from respiratory tract infection who were using endotracheal tube and admitted in critical care (41.7%).
Urinary tract infection caused by MDR-A.baumnaii (1.2%) while blood stream infection (8.3%). Source of MDR-A. baumanii isolate according to the specimen type was shown in Table 1 . The characteristic of A. baumanii infected patient were shown in Table 2 . The majority of patients were male (56%) with their age ranged between 14 to 65 year-old (73.8%). The patients with 0 to 14 years age range had the fewest number (7.2%), followed by >65 years (19%). A total of 39 (46.6%) patients were suffering from A. baumanii infection when admitted in critical care, and there were 1 (1.1%) patients admitted in pediatric department.
The frequency of MDR-A. baumanii which fluctuates during two-year observation was shown in Figure 1 . The highest prevalence was in April 2013 and followed in May 2014. In accordance with this result, the number of A. baumanii isolates tested was higher in 2013 with 45 incidence and decline in 2014 with 39 incidences.
The antibiotic susceptibility level of MDR-A. baumanii to 11 antibiotic regimens was shown in Figure 2 . Mostly A. baumanii isolate were multi-drug resistant. The susceptibility level was low to some antibiotic tested, 
Discussion
MDR-A. baumanii is a serious hospital acquired pathogen that has wide clinical spectrum, such as pneumonia, bacteriemia, urinary tract infection, surgical site infection especially in patients with medical devises, long duration of hospitalization, impaired immune response [10] [11] . Therefore, 46.6% patients who were admitted in intensive care in this study had high risk to acquired A. baumanii infection. Several studies have found that patients with co-morbidities and severe ill easily infected/colonized with this organism. However, the relationship between MDR-A. baumanii infection/colonization with co-morbidities did not significantly affect mortality but responsible for poor clinical outcome, need for mechanical ventilation and reduce functional status [12] . Acinetobacter baumanii can affected in any age group, from 0 year up to above 65 years, but most cases in this study were found in the aged group 14 -65 year-old (73.8%), followed by elderly patients 19%. These results were similar with other study that shown MDR-A. baumanii infection was responsible for infection in patients aged group 0 -80 year-old followed by the frequently affected in the age group above 60 years [4] [13] .
A. baumanii in this study mainly isolated from lower respiratory tract (72.6%). These findings were similar with other result where A. baumanii was recovered from 45% -50% patients [8] [13] . This organism also responsible for wound infection in 22.6% which much the same with the study that conducted in Saudi Arabia and Turkey, where the isolation rate was 22.3% and 27.5% [13] [14] . Bacteriemia caused by A. baumanii was found in 3.6% isolates and much alike with the previous study [13] . The last decades, there were increase hospital acquired infections by MDR-A. baumanii globally including Indonesia [11] . All isolates in this study were resistant to almost antibiotic classes and only susceptible to amikacin and trimethoprim-sulfamethoxazole. The growing prevalence of carbapenem resistance in this study was accordance with the other study in Turkey [15] [16]. This situation is also in line with the increased of inappropriate antibiotic consumption or overuse of ciprofloxacin and carbapenems in the hospital [13] [17] [18] .
Conclusion
A. baumanii is a hospital acquired pathogen in critically-ill patients. The susceptibility pattern of this study result showed MDR organism. There was a sharp decrease of susceptibility in all antibiotics studied from 2013 to 2014 except amikacin and trimethoprim-sulfamethoxazole.
